Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2017, Article ID 9475180, 4 pages
https://doi.org/10.1155/2017/9475180
Case Report

Epoetin Alfa: A Cause of Coronary Artery Thrombosis

1Lakeview Medical Center, Marshfield Clinic, Rice Lake, WI, USA
2Englewood Hospital and Medical Center, Englewood, NJ, USA
3DOW Medical College, Karachi, Pakistan

Correspondence should be addressed to Muhammad Umer Siddiqui; moc.liamg@remu.iqiddis

Received 5 June 2017; Accepted 10 August 2017; Published 1 October 2017

Academic Editor: Hajime Kataoka

Copyright © 2017 Muhammad Umer Siddiqui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Bennett, S. M. Silver, B. Djulbegovic et al., “Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia,” Journal of the American Medical Association, vol. 299, no. 8, pp. 914–924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Besarab, W. K. Bolton, J. K. Browne et al., “The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin,” The New England Journal of Medicine, vol. 339, no. 9, pp. 584–590, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. A. K. Singh, L. Szczech, K. L. Tang et al., “Correction of anemia with epoetin alfa in chronic kidney disease,” The New England Journal of Medicine, vol. 355, no. 20, pp. 2085–2098, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. H. L. Corwin, A. Gettinger, T. C. Fabian et al., “Efficacy and safety of epoetin alfa in critically ill patients,” The New England Journal of Medicine, vol. 357, no. 10, pp. 965–976, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Medical Officer Clinical Review: Darbepoetin Alfa (Aranesp) for The Treatment of Anemia Associated with Chronic Renal Failure, Office of Therapeutics Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Md, USA, 2001.
  6. L. D. Berrizbeitia, P. Wry, and J. Fernandez, “Repair of acute type A aortic dissection without the use of blood products,” Heart and Lung: Journal of Acute and Critical Care, vol. 37, no. 4, pp. 296–298, 2008. View at Publisher · View at Google Scholar · View at Scopus